# The Preterm Infants' Paracetamol Study

Study · id `cardio:ct-nct01938261` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01938261](<https://clinicaltrials.gov/study/NCT01938261>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01938261

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01938261. Randomized; quadruple masking; primary purpose prevention. Start 2013-08 (actual); primary completion 2024-07-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01938261, source copy `cardio:ctgov-nct01938261-2024-10-18`, retrieved 2026-10-26)
- Started: 2013-08 (actual) (ClinicalTrials.gov record NCT01938261, source copy `cardio:ctgov-nct01938261-2024-10-18`, retrieved 2026-10-26)
- Primary completion: 2024-07-15 (actual) (ClinicalTrials.gov record NCT01938261, source copy `cardio:ctgov-nct01938261-2024-10-18`, retrieved 2026-10-26)
- Completion: 2024-08-08 (actual) (ClinicalTrials.gov record NCT01938261, source copy `cardio:ctgov-nct01938261-2024-10-18`, retrieved 2026-10-26)
- Countries: Finland (ClinicalTrials.gov record NCT01938261, source copy `cardio:ctgov-nct01938261-2024-10-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01938261-2024-10-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Preterm Infants' Paracetamol Study
- Acronym: PreParaS
- Condition: Persistent Ductus Arteriosus
- Condition: Complication of Prematurity
- Condition: Pain or Discomfort in Intensive Care of Preterm Infants
- Intervention (Drug): paracetamol
- Intervention (Drug): 0.45 % saline solution
- Lead sponsor: University of Oulu
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)

## Provenance

Content hash: 5fcd7ae098ea2b135790389a39ff6179a3af10bf752688e65a1b8c00f03d2c6c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
